Aybintio (abaloparatide)
Aybintio is a prescription medicine used to treat osteoporosis in postmenopausal women at high risk…
Risk of Hemolytic Disease of the Newborn (HDN) when an Rh-negative mother carries an Rh-positive fetus When an Rh-negative mother carries an Rh-positive fetus, there is a risk of hemolytic disease of the newborn (HDN) because the mother’s immune system may produce antibodies against the Rh antigen in the fetal blood, leading to the destruction…… Read More »
The management of blood group incompatibility during pregnancy requires close collaboration between obstetricians, maternal-fetal medicine specialists, neonatologists, and other healthcare providers to ensure optimal outcomes for both mother and baby…. Read More »